SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-225762
Filing Date
2009-11-05
Accepted
2009-11-05 17:19:01
Documents
7
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 541634
2 WAIVER AND SECOND AMENDMENT TO CREDIT AGREEMENT dex101.htm EX-10.1 22373
3 THIRD AMENDMENT TO CREDIT AGREEMENT dex102.htm EX-10.2 35617
4 CERTIFICATION BY LEONARD BELL, CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 9482
5 CERTIFICATION BY VIKAS SINHA, V.P. AND CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 9300
6 CERTIFICATION BY LEONARD BELL, CEO PURSUANT TO SECTION 906 dex321.htm EX-32.1 4034
7 CERTIFICATION BY VIKAS SINHA, V.P. AND CFO PURSUANT TO SECTION 906 dex322.htm EX-32.2 4048
  Complete submission text file 0001193125-09-225762.txt   627871
Mailing Address 352 KNOTTER DRIVE CHESHIRE CT 06511
Business Address 352 KNOTTER DRIVE CHESHIRE CT 06511 2037761790
ALEXION PHARMACEUTICALS INC (Filer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27756 | Film No.: 091162068
SIC: 2834 Pharmaceutical Preparations